NIH-funded research R01 grant

Characterization of a LILRB3 SNP cluster and its link to kidney transplant outcomes

Official title: Characterization of a LILRB3 SNP cluster in kidney transplant recipients associated with post-transplant renal failure

Funded at Icahn School of Medicine at Mount Sinai · NIH-11434426 · Data updated 2026-11-12

A study in kidney transplant recipients looks at genetic factors that may be tied to higher risk of graft failure.

More Transplant research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 15, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$910,670
NIH project number1R01DK149129-01
Project IDNIH-11434426 on NIH RePORTER

Who could benefit from this research

Could help

Adults who have received a kidney transplant and carry or are suspected to carry LILRB3 SNP variants, or have suspected alloimmune-related risks.

Less likely to help

Patients without the LILRB3 SNP cluster or without post-transplant risk factors may see limited benefit.

What this research studies

This project will examine a cluster of LILRB3 gene SNPs that have been linked to poorer kidney transplant results by analyzing patient blood and transplant data across multiple centers. Researchers will relate genetic variants to immune signaling pathways and kidney function after transplantation. The goal is to understand whether these genetic differences help explain why some patients experience graft failure despite similar clinical factors. The study builds on previous findings and will use RNA sequencing and clinical data to explore these associations. Results could point toward new biomarkers or targets to improve graft survival for affected patients.

Why it matters

Potential benefit: If successful, the findings could lead to better risk stratification and personalized management to improve graft survival in patients with these genetic variants.

How similar studies have gone: Earlier work linked LILRB3 SNPs to post-transplant outcomes and immune signaling, with validation in external cohorts.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Zhang, Weijia — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Zhang, Weijia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.